Related Experiment Video
Updated: Aug 7, 2026
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
High density lipoprotein: guardian of the vascular system?
Insights
High-density lipoprotein cholesterol (HDL-C) protects against coronary heart disease (CHD) and atherosclerosis. Lifestyle changes and medications can increase HDL-C, making it a potential therapeutic target.
Area of Science:
- Cardiology
- Metabolic Syndrome Research
- Lipidology
Background:
- Low-density lipoprotein's role in coronary heart disease (CHD) is established.
- High-density lipoprotein cholesterol (HDL-C) shows strong inverse correlation with premature CHD.
- Low HDL-C is frequently associated with metabolic syndrome, central obesity, and insulin resistance.
Purpose of the Study:
- To review the evidence supporting HDL-C as a protective factor against atherosclerosis.
- To discuss the link between low HDL-C, metabolic syndrome, and type 2 diabetes.
- To explore methods for increasing HDL-C levels.
Main Methods:
- Literature review of studies on HDL-C and cardiovascular disease.
- Analysis of the association between HDL-C, metabolic syndrome, and type 2 diabetes.
- Evaluation of lifestyle interventions and pharmacological agents affecting HDL-C.
Main Results:
- Elevated HDL-C levels are linked to a reduced risk of atherosclerosis and premature CHD.
- Metabolic syndrome, prevalent in low HDL-C patients, is a significant factor in type 2 diabetes.
- Lifestyle modifications (weight loss, exercise, smoking cessation) and medications (fibrates, niacin, statins) effectively increase HDL-C.
Conclusions:
- HDL-C is a crucial inverse predictor of coronary events and atherosclerosis.
- Increasing HDL-C levels through lifestyle or pharmacological means is a viable strategy.
- HDL-C should be considered a primary therapeutic target for cardiovascular disease prevention.
Abstract:
The role of low-density lipoprotein in the development of coronary heart disease (CHD) is well recognised. There is also growing evidence that high-density lipoprotein cholesterol (HDL-C) is a powerful inverse predictor for premature CHD and that maintaining a high HDL-C level may guard against atherosclerosis. Patients with low HDL-C levels often also have central obesity, insulin resistance and other features of the metabolic syndrome. This syndrome is both increasingly common and strongly implicated in the growing worldwide epidemic of type 2 diabetes. HDL-C may be increased by lifestyle changes, e.g. weight loss, physical activity and smoking cessation. Pharmacological agents such as fibrates, niacin and statins have also been shown significantly to elevate HDL-C. Although current guidelines are beginning to recognise the protective role of HDL-C level in preventing coronary events, HDL-C should be adopted soon as a target for intervention in its own right.
Related Concept Videos
01:31Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:18Lipids: Dietary Sources and Requirements
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:26Coronary Artery Disease IV: Preventive Measures